About: http://data.cimple.eu/news-article/46d538cb9a064324a6f12827727975381bf8e9c2b598cbed0fed176f

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: http://data.cimple.eu/news-article/46d538cb9a064324a6f12827727975381bf8e9c2b598cbed0fed176f Goto Sponge NotDistinct Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

Attributes	Values
rdf:type	schema:NewsArticle
schema:articleBody	A new tuberculosis treatment that slashes costs and the pill burden for patients will be rolled out in five high-incidence countries this year, international medical research body the Aurum Institute said Wednesday. TB -- a respiratory disease that is preventable and treatable yet kills more than 1.4 million people every year -- is chronically underfunded, with diagnosis and treatment failing to reach millions. It is currently the world's deadliest infectious disease, with progress to stop its spread unwound by the Covid-19 pandemic as restricted movement disrupted treatment. "Enough treatments for up to three million patients are expected to be made available for eligible countries this year," Aurum said in a statement. The new two-drug regime will reduce the weekly pill intake for patients from nine to three. This is expected to enable better adherence and outcomes, Dr Tereza Kasaeva, the World Health Organisation's global TB programme director said. Treatment will initially be administered in Ethiopia, Ghana, Kenya, Mozambique and Zimbabwe. Seven other nations will follow later. A deal cut between the manufacturer Macleods, Unitaid and the Clinton Health Access Initiative (CHAI) will cap the price at $15 for a three-month complete regime. Aurum Institute's CEO Gavin Churchyard said the new treatment regime coupled with the price reduction would hopefully help get their aim of eradicating TB by 2030 back on track. "We lose in the end if Covid-19 mortality goes down, but TB rates go up," he warned. ho/mgu/ri
schema:headline	New TB treatment to cut pill intake by two-thirds: researchers
schema:mentions	Unitaid Respiratory disease Mozambique Infection Seven Network Tuberculosis Zimbabwe Mortality rate Ethiopia Clinton Foundation Ghana World Health Organization Kenya Chief executive officer Pandemic Coronavirus disease 2019 The Quarto Group Polypharmacy Unwound Interest rate cap and floor
schema:author	http://data.cimple.eu/organization/1f0054d541e000623a2c1e561a247c073ef6328e8be9ffafda7b3fcd
schema:datePublished	2021-02-03 (xsd:date)
http://data.cimple...sPoliticalLeaning	other political leaning
http://data.cimple...logy#hasSentiment	positive sentiment
http://data.cimple...readability_score	77 (xsd:integer)

Faceted Search & Find service v1.16.115 as of Oct 09 2023

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 3 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software